Since the rise of the pandemic COVID 19, we see a variety of clinical manifestations of Corona virus multisystem wise. During and post infection, patients are prone for cardiac diseases and its complications, even sudden deaths following thromboembolism. Fungal infections are also now making their way into this pandemic as secondary infections due to altered immunity in these individuals. We present a patient of COVID 19 infection who developed dual infection– mucormycosis and actinomycosis. We also report about mucor mycosis in a non COVID patient who was immunocompromised due to diabetes mellitus.